Neural tube defects can be prevented by folic acid, although the mecha
nism of this action is unclear. Studies of a series of folate-related
enzymes have so far failed to pin-point the nature of the metabolic de
fect in the neurulation-stage embryo that is corrected by folic acid.
Approximately 30% of neural tube defects appear resistant to folic aci
d and recent work in a mouse genetic model system suggests that admini
stration of myo-inositol may be a complementary therapeutic option. Th
e large number of mouse genes known to cause neural tube defects provi
de a starting point for identifying the genetic basis of the human def
ects. (C) 1998 Rapid Science Ltd.